Search This Blog

Tuesday, March 31, 2026

William Blair upgrades 10x Genomics (TXG) to Outperform from Market Perform

 


  • William Blair cites 10x Genomics' key role in enabling high‑resolution biological insights.
  • Upgrade also reflects improved execution and profitability trends at 10x Genomics.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.